177 related articles for article (PubMed ID: 32975001)
21. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?
Durkan GC; Greene DR
BJU Int; 1999 Jan; 83(1):34-8. PubMed ID: 10233448
[TBL] [Abstract][Full Text] [Related]
22. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies.
Pryor MB; Schellhammer PF
Clin Prostate Cancer; 2002 Dec; 1(3):172-6. PubMed ID: 15046692
[TBL] [Abstract][Full Text] [Related]
23. The use of prostate specific antigen density to predict clinically significant prostate cancer.
Yusim I; Krenawi M; Mazor E; Novack V; Mabjeesh NJ
Sci Rep; 2020 Nov; 10(1):20015. PubMed ID: 33203873
[TBL] [Abstract][Full Text] [Related]
24. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
[TBL] [Abstract][Full Text] [Related]
25. Does free to total ratio of prostate-specific antigen alter decision-making on prostatic biopsy?
Alivizatos G; Deliveliotis C; Mitropoulos D; Raptides G; Louras G; Karayiannis A; Becopoulos T; Dimopoulos AM
Urology; 1996 Dec; 48(6A Suppl):71-5. PubMed ID: 8973704
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging-guided biopsies may improve diagnosis in biopsy-naive men with suspicion of prostate cancer.
Winther MD; Balslev I; Boesen L; Logager V; Noergaard N; Thestrup KD; Thomsen HS
Dan Med J; 2017 May; 64(5):. PubMed ID: 28552089
[TBL] [Abstract][Full Text] [Related]
27. Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning.
Simmons LAM; Kanthabalan A; Arya M; Briggs T; Charman SC; Freeman A; Gelister J; Jameson C; McCartan N; Moore CM; van der Muelen J; Emberton M; Ahmed HU
Prostate Cancer Prostatic Dis; 2019 May; 22(2):261-267. PubMed ID: 30279583
[TBL] [Abstract][Full Text] [Related]
28. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
[No Abstract] [Full Text] [Related]
29. Clinical usefulness of free PSA in early detection of prostate cancer.
Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
Knaapila J; Gunell M; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Hakanen AJ; Boström PJ
Eur Urol Focus; 2019 May; 5(3):443-448. PubMed ID: 29275146
[TBL] [Abstract][Full Text] [Related]
31. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
32. Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.
Lai WJ; Wang HK; Liu HT; Park BK; Shen SH; Lin TP; Chung HJ; Huang YH; Chang YH
J Chin Med Assoc; 2016 Nov; 79(11):618-624. PubMed ID: 27567440
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
34. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
[TBL] [Abstract][Full Text] [Related]
35. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic values of digital rectal examination, prostate specific antigen and trans-rectal ultrasound in men with prostatism.
Manyahi JP; Musau P; Mteta AK
East Afr Med J; 2009 Sep; 86(9):450-3. PubMed ID: 21644416
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia.
Yii RSL; Lim J; Sothilingam S; Yeoh WS; Fadzli AN; Ong TA; Kuppusamy S; Abdul Razack AH
Asian J Surg; 2020 Jan; 43(1):87-94. PubMed ID: 30962017
[TBL] [Abstract][Full Text] [Related]
38. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
[TBL] [Abstract][Full Text] [Related]
39. Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.
Loch T
World J Urol; 2007 Aug; 25(4):375-80. PubMed ID: 17694312
[TBL] [Abstract][Full Text] [Related]
40. Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.
Sidana A; Watson MJ; George AK; Rastinehad AR; Vourganti S; Rais-Bahrami S; Muthigi A; Maruf M; Gordetsky JB; Nix JW; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
Urol Oncol; 2018 Jul; 36(7):341.e1-341.e7. PubMed ID: 29753548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
